Schutt Aj

579 citations
33 papers · 483 · h-index 12

Impact in

  • Oncology top 10%
    • Colorectal Cancer Treatments and Studies
    • Pancreatic and Hepatic Oncology Research
    • Cancer Treatment and Pharmacology
    • Lung Cancer Research Studies
  • Neurology top 10%
    • Neuroblastoma Research and Treatments

Papers in

    • Colorectal Cancer Treatments and Studies 9
    • Cancer Treatment and Pharmacology 4
    • Cancer therapeutics and mechanisms 4

Schutt Aj

32 papers receiving 396 citations

Peers

Schutt Aj
Comparison fields: 5 of 68
  • Oncology 240
  • Neurology 84
  • Gastroenterology 26
  • Epidemiology 143
  • Pathology and Forensic Medicine 49
Replace R. Brunet with:
R. Brunet France
K Fischerman Denmark
Chabner Ba United States
Beger Hg Germany
G Martz Switzerland
Yoshikazu Kamiya Japan
Stephen H. Rosenoff United States
Richárd Schwab Hungary
Toshiki Kamano Japan
M Fukushima Japan
Schutt Aj relative to R. Brunet France R. Brunet's profile →
Citations per field
00.5×1.5×2.2×
R. Brunet · 1×
Citations per year

Countries citing papers authored by Schutt Aj

Since Specialization
Citations

This map shows the geographic impact of Schutt Aj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Schutt Aj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Schutt Aj more than expected).

Fields of papers citing papers by Schutt Aj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Schutt Aj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Schutt Aj. The network helps show where Schutt Aj may publish in the future.

Co-authors

The 16 scholars most cited alongside Schutt Aj, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Schutt Aj Line = papers co-authored together Schutt Aj links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Carcinoid tumors of the gastrointestinal tract: presentation, management, and prognosis.
1985144
2
Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel.
197451
3
Therapy for gastrointestinal cancer with the nitrosoureas alone and in drug combination.
197630
4
Treatment of advanced squamous cell carcinoma of the gastrointestinal tract with bleomycin (NSC-125066).
197426
5
Phase II study of 5-azacytidine (NSC-102816) in the treatment of advanced gastrointestinal cancer.
197224
6
Diagnosis of Meckel's diverticulum by radioisotope scanning.
197323
7
Phase II study of ICRF-159 (NSC-129943) in advanced colorectal carcinoma.
197523
8
Effects of patient selection on results of phase II chemotherapy trials in gastrointestinal cancer.
197422
9
Phase II studies of dianhydrogalactitol and VP-16-213 in colorectal cancer.
197620
10
Phase I study of N-(phosphonacetyl)-L-aspartic acid (PALA).
198015
11
Phase II study of the combination of vinblastine, bleomycin, and cisplatin in advanced malignant melanoma.
198212
12
Phase II study of PALA in advanced large bowel carcinoma.
198111
13
Phase II study of high-dose megestrol acetate in patients with advanced malignant melanoma.
198210
14
Phase II trial of indicine N-oxide (INDI) in patients with advanced colorectal carcinoma.
19818
15
Adjuvant therapy for colon cancer.
19957
16
Phase II trial of iv 6-thioguanine in advanced colorectal carcinoma.
19815
17
Phase II study of the combination of vinblastine plus cisplatin administered by continuous 120-hour infusion for patients with advanced malignant melanoma.
19875
18
Phase II study of pyrazofurin in advanced colorectal carcinoma.
19775
19
Phase II study of hycanthone in patients with advanced colorectal carcinoma.
19834
20
Phase II study of mitolactol and semustine combination chemotherapy for advanced malignant melanoma.
19824

About Schutt Aj

Schutt Aj is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Surgery and Biotechnology, having authored 33 papers that have together received 483 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (9 papers), Gastric Cancer Management and Outcomes (6 papers), Cancer Treatment and Pharmacology (4 papers), Cancer therapeutics and mechanisms (4 papers), Cancer Research and Treatments (4 papers), Colorectal and Anal Carcinomas (3 papers), Multiple and Secondary Primary Cancers (2 papers) and Beetle Biology and Toxicology Studies (2 papers). The work is most often cited by research in Oncology (240 citations), Neurology (84 citations), Gastroenterology (26 citations), Epidemiology (143 citations) and Pathology and Forensic Medicine (49 citations). Schutt Aj has collaborated with scholars based in United States. Frequent co-authors include Moertel Cg, Robert G. Hahn, van Heerden Ja, Ilstrup Dm, Carney Ja, Martin Jk, O'Connell Mj, Adson Ma, J. Purvis and Stephen Frytak. Their work appears in journals such as PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact